Skip to Content
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 10/10/18

Lymphoma SPOREs

There are two distinct subtypes of this disease — Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). According to the Surveillance, Epidemiology and End Results (SEER) Program data, it is estimated that in 2016 there will be a total of 81,080 new cases of lymphoma in the U.S. Of these, 72,580 are expected to be NHL cases and 8,500 cases will be HL. In 2016 a total of 19,020 people are expected to die of NHL while 1,180 HL deaths are expected. The incidence of NHL doubled from 1975 to 2004 but has leveled off since then. The five-year survival rate for patients with NHL has increased from 45.8% in 1975 to 72.5% in 2008. HL had a five-year survival rate of 69.9% in 1975 and by 2008 the survival rate had reached 90.4 due to improved therapies. Despite these favorable trends, lymphomas remain a serious medical problem affecting thousands of individuals.